1. Endo Pharmaceuticals. Prescribing information for SYMMETREL® (amantadine hydrochloride, USP) tablets and syrup. 2009.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/016023s041,018101s016lbl.pdf
. Accessed 7 Nov 2017.
2. Aoki FY, Sitar DS. Clinical pharmacokinetics of amantadine hydrochloride. Clin Pharmacokinet. 1988;14(1):35–51.
3. Muller T, Kuhn W, Quack G, Przuntek H. Intravenous application of amantadine and antiparkinsonian efficacy in Parkinsonian patients. J Neural Transm Suppl. 1995;46:407–13.
4. Somani SK, Degelau J, Cooper SL, Guay DR, Ehresman D, Zaske D. Comparison of pharmacokinetic and safety profiles of amantadine 50- and 100-mg daily doses in elderly nursing home residents. Pharmacotherapy. 1991;11(6):460–6.
5. Vargus-Adams JN, McMahon MA, Michaud LJ, Bean J, Vinks AA. Pharmacokinetics of amantadine in children with impaired consciousness due to acquired brain injury: preliminary findings using a sparse-sampling technique. PM R. 2010;2(1):37–42.